Cory Jubinville, PhD
Stock Analyst at LifeSci Capital
(4.73)
# 686
Out of 4,604 analysts
166
Total ratings
52.7%
Success rate
26.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville, PhD
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Maintained: Buy | $6 | $2.98 | +101.34% | 9 | Jul 24, 2026 | |
| TNYA Tenaya Therapeutics | Maintained: Buy | $4 | $0.7416 | +439.37% | 32 | Jul 23, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.3221 | - | 14 | Jan 12, 2026 | |
| CRNX Crinetics Pharmaceuticals | Maintained: Buy | $93 → $99 | $83.86 | +18.05% | 30 | Jan 5, 2026 | |
| SION Sionna Therapeutics | Initiated Coverage: Buy | $60 | $49.94 | +20.14% | 1 | Dec 23, 2025 | |
| IKT Inhibikase Therapeutics | Initiated Coverage: Buy | $5 | $2.44 | +104.92% | 1 | Dec 1, 2025 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $88 | $29.17 | +201.68% | 5 | Nov 18, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintained: Buy | $9 | $3.44 | +161.63% | 17 | Nov 7, 2025 | |
| LRMR Larimar Therapeutics | Maintained: Buy | $22 | $4.11 | +435.28% | 21 | Nov 5, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $85 → $84 | $61.11 | +37.46% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $67 | $88.38 | -24.19% | 22 | Nov 3, 2025 |
Prime Medicine
Jul 24, 2026
Maintained: Buy
Price Target: $6
Current: $2.98
Upside: +101.34%
Tenaya Therapeutics
Jul 23, 2026
Maintained: Buy
Price Target: $4
Current: $0.7416
Upside: +439.37%
Mereo BioPharma Group
Jan 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.3221
Upside: -
Crinetics Pharmaceuticals
Jan 5, 2026
Maintained: Buy
Price Target: $93 → $99
Current: $83.86
Upside: +18.05%
Sionna Therapeutics
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $60
Current: $49.94
Upside: +20.14%
Inhibikase Therapeutics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.44
Upside: +104.92%
Tectonic Therapeutic
Nov 18, 2025
Maintained: Buy
Price Target: $88
Current: $29.17
Upside: +201.68%
Rocket Pharmaceuticals
Nov 7, 2025
Maintained: Buy
Price Target: $9
Current: $3.44
Upside: +161.63%
Larimar Therapeutics
Nov 5, 2025
Maintained: Buy
Price Target: $22
Current: $4.11
Upside: +435.28%
Tarsus Pharmaceuticals
Nov 5, 2025
Maintained: Buy
Price Target: $85 → $84
Current: $61.11
Upside: +37.46%
Nov 3, 2025
Maintained: Buy
Price Target: $54 → $67
Current: $88.38
Upside: -24.19%